首页> 外国专利> Compositions comprising phytoestrogens selectively agonist to the estrogen beta receptor and dietary fibres and use thereof for preparation of medicaments for treating intestinal mucosa pathological conditions

Compositions comprising phytoestrogens selectively agonist to the estrogen beta receptor and dietary fibres and use thereof for preparation of medicaments for treating intestinal mucosa pathological conditions

机译:包含对雌激素β受体和膳食纤维选择性激动的植物雌激素的组合物及其在制备用于治疗肠粘膜病理性疾病的药物中的用途

摘要

Oral compositions comprising an association of one or of a mixture of phytoestrogens, selective for the estrogen receptor-, with dietary fibres are described. The compositions thereof can be profitably used for the prophylactic and therapeutic treatment in mammals, including humans, of health conditions characterised by a high risk of onset and recurrence of intestinal adenomas (adenopolyposis coli), and of adenoma's progression to colorectal carcinoma. In presence of pre-cancerous lesions in the colon, characterised by mutations of the APC tumor suppressor and defined as polyps or adenomas, the oral compositions disclosed can be in fact profitably used to reduce the number and volume of polyps, and to prevent their progression to neoplastic transformation, reducing their degree of dysplasia.
机译:描述了一种口服组合物,其包含对雌激素受体具有选择性的植物雌激素的一种或混合物与膳食纤维的缔合。其组合物可有益地用于包括人在内的哺乳动物的疾病预防性和治疗性治疗,所述疾病的特征在于高发病率和复发性肠腺瘤(大肠息肉病)以及腺瘤发展成大肠癌的风险。在结肠中存在癌前病变,其特征在于APC肿瘤抑制物的突变并定义为息肉或腺瘤,所公开的口腔用组合物实际上可以有利地用于减少息肉的数量和体积,并防止其发展。进行肿瘤转化,减少其不典型增生的程度。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号